Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
Pharmacogenomics and Personalized Medicine2024Vol. Volume 17, pp. 91–103
Citations Over TimeTop 16% of 2024 papers
Abstract
The expression of GRHL1 was high in EC patients, and high expression of GRHL1 inhibits the proliferation of CD8+ T cells in the tumor microenvironment of EC and affect the efficacy of immunotherapy.
Related Papers
- → Immunotherapy and tumor microenvironment(2015)303 cited
- → Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)(2018)76 cited
- → Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications(2022)71 cited
- → Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance(2023)39 cited
- → Role of the tumor immune microenvironment in tumor immunotherapy (Review)(2021)41 cited